Compartir
Información de la revista
Número
Vol. 47. Núm. 6.Páginas 327-394 (Julio - Agosto 2023)
Editorials
Electronic cigarette: is it a risk factor for the development of bladder cancer?
C. Astudillo, H.A. García-Perdomo
Actas Urol Esp. 2023;47:327-8
BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
F. Guerrero-Ramos
Actas Urol Esp. 2023;47:329-31
Review articles
Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature
J. Ruiz Aragón, E. Jiménez Varo, A.I. Ruiz Aragón, I. Revelo Cadena, Á. Agüera Sánchez, M.E. Jiménez Romero
Actas Urol Esp. 2023;47:332-40
Systematic review of the implantation of penile prosthesis in major ambulatory surgery
J. Torremadé, M. Presa, Ó. Gorría, R. de Burgos, I. Oyagüez, E. Lledó
Actas Urol Esp. 2023;47:341-50
Renal transplantation in pediatric recipients: Considerations and preoperative assessment strategies
B. Bañuelos Marco, M.I. Dönmez, T. Geppert, T. Prudhomme, R. Campi, B. Mesnard, V. Hevia, R. Boissier, ... on behalf of EAU - YAU Kidney Transplant, Pediatric Working Groups
Actas Urol Esp. 2023;47:351-9
Original articles
Quality of life in patients with non-muscle invasive bladder tumor undergoing adjuvant intravesical treatment
J. Panach-Navarrete, A. Devís-Peiró, M.A. Lloret-Durà, S. Sánchez-Gimeno, E. Murcia-Díez, J.M. Martínez-Jabaloyas
Actas Urol Esp. 2023;47:360-8
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic
S. Castellarnau, J.M. Gaya, J. Espinosa, P. Sierra, J. Huguet, J. Palou, D. Hernando, S. Sabaté, A. Breda
Actas Urol Esp. 2023;47:369-75
Prognostic factors and treatment outcomes for female urinary incontinence rehabilitation
E.J. Frutos-Reoyo, P. Luque-Linero, E. Cantalapiedra-Puentes, I. Mendi-Gabarain, P. Bermejo-de la Fuente, E.D. Candau-Pérez
Actas Urol Esp. 2023;47:376-81
Early readmissions post kidney transplantation: lessons learned
M. Moein, I.M. Vlassis, L. Kim, M. Hanlon, R. Saidi
Actas Urol Esp. 2023;47:382-9
Letters to the editor
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer
R. García-Fumero, M. Piñero-González
Actas Urol Esp. 2023;47:390-2
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply
A. Borque-Fernando, M.A. Calleja-Hernández, J.M. Cózar-Olmo, A. Gómez-Iturriaga, D.A. Pérez-Fentes, J. Puente-Vázquez, M. Rodrigo-Aliaga, M. Unda, J.L. Álvarez-Ossorio
Actas Urol Esp. 2023;47:392-3
Publique en
Actas Urológicas Españolas
Contenido especial sobre COVID-19
- Association between COVID-19 and increased incidence of overactive bladder symptoms in female patients: A retrospective analysis
- Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up
- Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic
- External validation of the current scoring systems and derivation of a novel scoring system to predict stone free rates after retrograde intrarenal surgery in patients with cumulative stone diameter of 2–4 cm
Actas Urológicas Españolas (English Edition) se adhiere a los principios y procedimientos dictados por el Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.
Artículos de acceso gratuito
Actas Urol Esp. 2024;48:11-8
Actas Urol Esp. 2024;48:162-9
Actas Urol Esp. 2024;48:79-104